Loading…
PerkinElmer has agreed to acquire Horizon Discovery Group for approximately $383 million, adding gene editing and gene modulation tools to its life sciences portfolio.
Horizon Discovery Group PLC completed the acquisition of GE Healthcare's Dharmacon business for $85 million, funded through cash, shares and an £80 million placing.